De Novo Sequencing of Proteins: How to Improve Accuracy and Data Analysis Efficiency
De novo protein sequencing is a method for directly resolving the amino acid sequence of proteins through mass spectrometry (MS) without the need for a reference genome or known protein database. Compared to database search-based protein identification methods, this technique can identify novel proteins, peptide modification variants, and protein sequences from non-model organisms. However, due to the complexity of mass spectrometry data, the diversity of fragment ions, and noise interference, the accuracy and data analysis efficiency of de novo sequencing still face many challenges. Optimizing experimental design, improving data quality, and employing efficient algorithms for analysis remain key areas of ongoing research in this field.
I. Optimize mass spectrometry techniques to improve data quality
Advancements in mass spectrometry technology are crucial for the accuracy of de novo protein sequencing. High-resolution mass spectrometry (such as Orbitrap, FT-ICR MS) can provide more precise m/z measurements, enhancing peptide identification capabilities. Tandem mass spectrometry (MS/MS) selectively fragments peptides to generate b ion and y ion sequence information, which can be used to deduce amino acid sequences. In experimental design, optimizing collision energy (CE) helps enhance fragmentation efficiency, avoiding over or under fragmentation. Additionally, using multiple fragmentation techniques, such as high-energy collision dissociation (HCD), electron-transfer dissociation (ETD), and electron-capture dissociation (ECD), can provide complementary fragment information and enhance peptide coverage.
II. Enhance algorithm performance to strengthen sequence analysis capabilities
The core of data analysis lies in efficient algorithms. Currently, major de novo protein sequencing algorithms include graph-based, dynamic programming, and deep learning methods. Graph-based algorithms (such as PEAKS) utilize signal connections in spectra to construct paths and find the optimal amino acid sequence. Dynamic programming methods (such as DirecTag) use continuous signal patterns to match and improve peptide assembly accuracy. In recent years, deep learning methods (such as DeepNovo) leverage large-scale training data to improve prediction accuracy in complex noise backgrounds. Combining multiple algorithm strategies and using multi-stage filtering strategies to remove low-confidence fragments can further enhance analysis accuracy.
III. Data post-processing and result validation to ensure result reliability
After obtaining the initial sequence, further data post-processing and result validation are equally important. First, remove redundant and low-quality data, for example, using statistical models to calculate confidence scores and screening reliable peptides based on peak intensity information. Secondly, cross-verification through matching known protein databases improves sequence reliability. Additionally, experimental validation methods such as Edman degradation, isotope labeling verification (such as SILAC, TMT), and synthetic peptide comparison can also assist in confirming the accuracy of sequences.
IV. Future development trends: smarter, more efficient, and more widespread
With the continuous advancement of mass spectrometry technology and computational methods, de novo protein sequencing will play a bigger role in novel protein identification, antibody sequence analysis, and protein post-translational modification research. Future research directions include:
1. Developing mass spectrometers with higher resolution and sensitivity to improve data quality.
2. Combining artificial intelligence and deep learning to optimize data analysis processes and reduce manual intervention.
3. Developing new bioinformatics tools to achieve integrated analysis of multiple fragmentation modes, increasing de novo sequencing coverage.
4. Combining multi-omics technologies (such as transcriptomics, metabolomics) to analyze protein functions and regulatory networks at the system level.
De novo protein sequencing is one of the technologies in the field of proteomics, and with continuous optimization, its application prospects will be even broader. While improving accuracy and data analysis efficiency, we can anticipate more precise mass spectrometry technology, smarter data analysis methods, and more efficient experimental strategies to jointly push protein research to new heights. Biotech company Bright Biotech offers high-quality de novo sequencing services, so feel free to contact us!
Bright Biotech - Characterization of Biological Products, Multimodal Biomass Spectrometry Testing Quality Service Provider
Related Services:
How to order?
